BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
797 results:

  • 1. Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake.
    Dai D; Yu J; Gou W; Yang S; Li Y; Wang Z; Yang Z; Huang T; Li P; Zhu T; Hou W; Zhao Y; Xu W; Li Y
    J Med Chem; 2024 Apr; 67(8):6726-6737. PubMed ID: 38570733
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
    Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
    Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
    Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
    Huang L; Lv Y; Guan S; Yan H; Han L; Wang Z; Han Q; Dai G; Shi Y
    J Transl Med; 2024 Feb; 22(1):184. PubMed ID: 38378604
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features.
    Tsilimigras DI; Han X; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Chaucy F; Koerkamp BG; Endo I; Sasaki K; Aucejo F; Zhang XF; Zhu H; Pawlik TM
    Ann Surg Oncol; 2024 May; 31(5):3087-3097. PubMed ID: 38347332
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cdkn2a-p16 Deletion and Activated KRAS
    Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
    Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mallory-Denk bodies and hepatocellular senescence: a causal relationship?
    Denk H; Abuja PM; Zatloukal K
    Virchows Arch; 2024 Apr; 484(4):637-644. PubMed ID: 38289501
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 9. First-in-human study of PSMA-targeting agent, [
    Zhao R; Ke M; Lv J; Liu S; Liu Y; Zhang J; Xu L; Gu D; Li M; Cai C; Liu Y; Zeng G; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1753-1762. PubMed ID: 38212531
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line.
    Huang J; Sun M; Wang M; Yu A; Zheng H; Bu C; Zhou J; Zhang Y; Qiao Y; Hu Z
    Bioengineered; 2024 Dec; 15(1):2296775. PubMed ID: 38184822
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Prognostic and Therapeutic Roles of ARL-6 Gene in Hepatocellular Carcinoma.
    Wang J; Che F; Zhao Y; Wei L; Chen D; Dai C; Zhang B; Zhou X; Yang B; Chen Z
    Int J Med Sci; 2024; 21(2):207-218. PubMed ID: 38169538
    [No Abstract]    [Full Text] [Related]  

  • 12. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Crosstalk of cuproptosis-related prognostic signature and competing endogenous RNAs regulation in hepatocellular carcinoma.
    Zhu J; Wang J; Liu H; Lei T; Yang J; Lan S; Jian H; Fang H; Zhang Y; Ren K; Zhong F
    Aging (Albany NY); 2023 Dec; 15(23):13901-13919. PubMed ID: 38078880
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
    Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
    BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reconstruction of the regulatory hypermethylation network controlling hepatocellular carcinoma development during hepatitis C viral infection.
    Antropova EA; Khlebodarova TM; Demenkov PS; Volianskaia AR; Venzel AS; Ivanisenko NV; Gavrilenko AD; Ivanisenko TV; Adamovskaya AV; Revva PM; Kolchanov NA; Lavrik IN; Ivanisenko VA
    J Integr Bioinform; 2023 Sep; 20(3):. PubMed ID: 37978846
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Increased Incidence of liver Metastases in Colorectal
    Garrett C; Cristaudo A; Barat S; Morris DL
    Anticancer Res; 2023 Oct; 43(10):4657-4662. PubMed ID: 37772565
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of Key Biomarkers in Hepatocellular Carcinoma Induced by Non-alcoholic steatohepatitis or Metabolic Syndrome via Integrated Bioinformatics Analysis.
    Wang B; Zhang Y; Gai L; He Y; Qiu H; Li P
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):174-180. PubMed ID: 37715392
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients.
    Peng H; Zou Z; Xiang Z; Lu X; Zhang Y; Peng X
    Medicine (Baltimore); 2023 Aug; 102(34):e34741. PubMed ID: 37653738
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice.
    Gu Y; Avolio E; Alvino VV; Thomas AC; Herman A; Miller PJ; Sullivan N; Faulkner A; Madeddu P
    Cardiovasc Diabetol; 2023 Aug; 22(1):214. PubMed ID: 37592236
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. All-
    Han J; Jang KL
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515144
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 40.